Pharma Stock Market Review

Latest Pharma Stock Updates

Phenomic AI starts with $6M using AI/ML for Targeting the Tumor Stroma

Phenomic AI, a Canadian biotechnology company that uses an AI/ML platform for targeting the tumor stroma, has launched with $6

letter of intent

Enzolytics and BioClonetics intent to merge sends stock parabolic

Enzolytics, Inc, a drug development company with a focus on debilitating infectious diseases, announced on September 16, the execution of

cardiovascular disease

BMS boosts cardiovascular pipeline with $13.1 Billion MyoKardia buy

Bristol Myers Squibb is strengthening its cardiovascular pipeline through a $13.1 Billion acquisition of biotech firm MyoKardia. The $13.1 Billion

Biotech firms raise $12.6B investment in H1 of 2020

Biotechnology has spearheaded the healthcare industry in investment action from private equity and venture capital during the first half of

venture capital decorative

BioMed Raises $177M to Accelerate Next-Gen Biologics Development

Harbour BioMed, a global clinical stage biopharmaceutical company developing novel therapeutics in the fields of immuno-oncology, immunologic diseases, and COVID-19,

pharma stock market

Top 3 Recession Proof Pharma Stocks 2020

These three pharmaceutical companies should be well shielded from the adverse effects of the looming economic downturn. According to the

U.S. Congress invests heavily in big pharma stocks

U.S Congress members seem to like trading big pharma stocks. Pfizer is one of the most popular pharma stocks in

decorative innovation image

The top 10 Pharmaceutical Innovation Index companies 2020

Success on the Innovation Index is important, especially now, at a time when innovation is needed more than ever. Many,

decorative pharma stock rise

Inovio Pharmaceuticals Stock up 16.36% as HPV drug shows promise

Inovio Pharmaceuticals stock soared by +16.36% on Friday, as HPV drug VGX-3100 showed promise in Phase 2 Trial. Shares of

decorative wall street

Coronavirus biotechnology stocks defying gravity

This week, biotechnology stocks on the verge of developing a coronavirus vaccine skyrocketed as the deadly virus sent the US